References
- Ebert U, Loffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol Ther 1997;74:207–220.
- Doll DC, Ringenberg QS, Yarbro JW. Management of cancer during pregnancy. Arch Intern Med. 1988;148:2058–2064.
- Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5:283–291.
- Gaillard B, Leng JJ, Grellet J, Ducint D, Saux MC. [Transplacental passage of epirubicin]. J Gynecol Obstet Biol Reprod (Paris) 1995;24:63–68.
- Goldwasser F, Pico JL, Cerrina J, Fernandez H, Pons JC, Cosset JM, Hayat M. Successful chemotherapy including epirubicin in a pregnant non-Hodgkin's lymphoma patient. Leukemia & Lymphoma 1995;20:173–176.
- Giacalone PL, Laffargue F, Benos P. Chemotherapy for breast carcinoma during pregnancy – A French national survey. Cancer 1999;86:2266–2272.
- Achtari C, Hohlfeld P. Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am J Obstet Gynecol 2000;183:511–512.
- Meyer-Wittkopf M, Barth H, Emons G, Schmidt S. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet Gynecol 2001;18:62–66.
- Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2001;2:173–177.
- Aviles A, Neri N, Nambo MJ. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol 2006;17:286–288.
- Siu BL, Alonzo MR, Vargo TA, Fenrich AL. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int J Gynecol Cancer 2002;12:399–402.
- Gadducci A, Cosio S, Fanucchi A, Nardini V, Roncella M, Conte PF, Genazzani AR. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: Case report and review of the literature. Anticancer Research 2003;23:5225–5229.
- Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol 2004;15:146–150.
- Peccatori F, Martinelli G, Gentilini O, Goldhirsch A. Chemotherapy during pregnancy: what is really safe? Lancet Oncology 2004;5:398.
- Andreadis C, Charalampidou M, Diamantopoulos N, Chouchos N, Mouratidou D. Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer. Gynecologic Oncology 2004;95:252–255.
- Ginopoulos P, Michail GD, Kourounis GS. Pregnancy associated breast cancer: A case report. European Journal of Gynaecological Oncology 2004;25:261–263.
- Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA. Chemotherapy for Breast Cancer During Pregnancy: An 18-Year Experience From Five London Teaching Hospitals. J Clin Oncol 2005;23:4192–4197.
- Van Calsteren K, Berteloot P, Hanssens M, Vergote I, Amant F, Ganame J, Claus P, Mertens L, Lagae L, Delforge M, In utero exposure to chemotherapy: effect on cardiac and neurologic outcome. J Clin Oncol 2006;24:e16–e17.
- Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, Yang W, Perkins G, Hortobagyi GN, Theriault RL. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006;107:1219–1226.
- Azim HA, Peccatori FA, Scarfone G, Acaia B, Rossi P, Cascio R, Goldhirsch A. Anthracyclines for gestational breast cancer: course and outcome of pregnancy. Annals of Oncology 2006;208:1511–1512.
- Loibl S, von Minckwitz G, Gwyn K, Ellis P, Blohmer JU, Schlegelberger B, Keller M, Harder S, Theriault RL, Crivellari D, Breast carcinoma during pregnancy – international recommendations from an expert meeting. Cancer [Review]. 2006;106:237–246.